Protective Effect of Kolaviron on Cyclophosphamide-Induced Cardiac Toxicity in Rats

Journal of Evidence-based Integrative Medicine
Joseph Gbenga OmoleBenson Akinloye Fadeyi

Abstract

Cyclophosphamide (CP) is a nitrogen mustard alkylating drug used for the treatment of chronic and acute malignant lymphomas, myeloma, leukemia, neuroblastoma, adenocarcinoma, retinoblastoma, breast carcinoma, and immunosuppressive therapy. Despite its vast therapeutic uses, it is known to cause severe cardiac toxicity. Kolaviron (KV), a Garcinia kola seed extract containing a mixture of flavonoids, is reputed for its antioxidant and membrane stabilizing properties. This study investigated the protective effect of KV on CP-induced cardiotoxicity in rats. Thirty rats were used, and they were divided into 6 groups of 5 rats each. Group I received 2 mL/kg propylene glycol orally for 14 days; group II received CP (50 mg/kg/d, intraperitoneally [i.p.]) for 3 days; groups III and IV received 200 and 400 mg/kg/d KV, respectively, orally for 14 days and groups V and VI were pretreated with 200 and 400 mg/kg/d KV, respectively, orally for 14 days followed by CP (50 mg/kg/d, i.p.) for 3 days. CP treatment resulted in a significantly lower food consumption and body weight in rats. The lactate dehydrogenase and creatine kinase enzymes in cardiac tissues of rats treated with CP were significantly higher. In cardiac tissues, 3-day doses of CP...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
May 1, 1990·Journal of Ethnopharmacology·A Akintonwa, A R Essien
Jan 1, 1985·Experimental Lung Research·J M Patel, E R Block
Feb 9, 1973·Science·J T RotruckW G Hoekstra
Jan 1, 1996·Free Radical Biology & Medicine·M SuzukiH Ishii
Feb 1, 1997·Analytical Biochemistry·Y Xia, J L Zweier
Jun 22, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·E O Farombi
Jul 6, 2000·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C A De SouzaE Damasio
Nov 15, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J O NwankwoG O Emerole
Jan 23, 2002·Chemico-biological Interactions·Julie C Kern, James P Kehrer
Apr 12, 2002·Physiological Genomics·Susan E Malley, Margaret A Vizzard
May 30, 2002·European Journal of Heart Failure·M I Gharib, A K Burnett
May 6, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Nina L TsakadzeStanley E D'Souza
Mar 16, 2004·Cell Biology and Toxicology·K Manda, A L Bhatia
Feb 4, 2005·Journal of Leukocyte Biology·Seymour J Klebanoff
Mar 16, 2005·Chemico-biological Interactions·Elangovan SelvakumarPalaninathan Varalakshmi
Mar 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Stephen J Nicholls, Stanley L Hazen
Aug 27, 2005·Clinical and Experimental Pharmacology & Physiology·E O Farombi, I A Nwaokeafor
Sep 10, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Subramanian SenthilkumarMunismay Suresh Babu
Dec 1, 2005·Molecular and Cellular Biochemistry·Periyasamy Thandavan SudharsanPalaninathan Varalakshmi
Aug 19, 2010·Oxidative Medicine and Cellular Longevity·Abdulaziz A Al-YahyaAdel R A Abd-Allah
Oct 20, 2010·Journal of Biochemical and Molecular Toxicology·Mahmoud N NagiMohamed M Sayed-Ahmed
Feb 21, 2013·Human & Experimental Toxicology·V AricaA Nacar
Mar 16, 2013·The Journal of Pharmacy and Pharmacology·Sadashivaiah JnaneshwariKesturu Subbaiah Girish
Aug 29, 2014·Journal of Dietary Supplements·Olatunde OwoeyeEbenezer O Farombi
Aug 22, 2017·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Quadri Kunle AlabiOluwole Olaniyi Odujoko

❮ Previous
Next ❯

Citations

May 31, 2018·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Quadri K AlabiAyowole A Oladele
Aug 14, 2019·Environmental Toxicology·Joseph G OmoleMokolade S Ige
Feb 9, 2020·Nutrients·Nurul 'Izzah IbrahimIsa Naina Mohamed
Oct 1, 2020·Pharmacology Research & Perspectives·Mohamed El-ShabrawyHanaa Wanas
May 27, 2020·Oxidative Medicine and Cellular Longevity·Muluken Altaye AyzaAbera Hadgu Berhe
Jun 26, 2020·Frontiers in Cell and Developmental Biology·Wanjun MaWenqun Li
Jul 28, 2020·Journal of Toxicology·Olufunke Esan OlorundareHasan Mukhtar
Apr 25, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Muluken Altaye AyzaAbera Hadgu Berhe
Dec 11, 2020·Drug Design, Development and Therapy·Emad H M HassaneinAyman M Mahmoud
Oct 27, 2020·Oxidative Medicine and Cellular Longevity·Małgorzata Kiełczykowska, Irena Musik
Feb 17, 2021·Clinical and Experimental Pharmacology & Physiology·Hanaa WanasBasma Emad Aboulhoda
Feb 27, 2021·International Journal of Radiation Biology·Amira Abd-ElRaoufHesham A Salem
Mar 26, 2021·Environmental Science and Pollution Research International·Adeoye Oyewole IdrisEzekiel Olugbenga Iwalewa
Jul 28, 2021·Current Problems in Cardiology·Ashot Avagimyan
Nov 4, 2021·BMC Complementary Medicine and Therapies·Quadri K AlabiDeborah Kajewole-Alabi
Dec 15, 2021·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Okezie EmmanuelEziuche A Ugbogu

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
biopsies
MDA

Software Mentioned

Graph Pad Prism

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.